Welcome to Thrombosis Adviser

A Venous & Arterial Thrombosis Resource
For

Adviser’s Picks

  • LINC 2019 Highlights
    Read more
  • Professor Craig I. Coleman about challenges in interpreting real-world studies involving the NOACs
    Read more
  • Extended Treatment of VTE: In Whom and at Which Dose?
    Read more
  • Further Advances on the Use of NOACs in Patients with AF Undergoing PCI
    Read more
  • 10 Years of Anticoagulation with the NOACs
    Read more
  • Managing Multimorbid Patient with Atrial Fibrillation
    Read more
  • Dual pathway strategy for secondary prevention of atherothrombotic events: the anticoagulant and antiplatelet mix
    Read more
  • Extended VTE treatment: insights from new data
    Read more
  • Cardioversion and Ablation: an Overview of Completed Studies and Clinical Perspectives
    Read more
  • Management of Patients with Atrial Fibrillation and Coronary Artery Disease: Practical Perspectives from PIONEER AF-PCI
    Read more
  • Impact of Common Co-Morbidities on Patient Selection for Non-Vitamin K Antagonist Oral Anticoagulants
    Read more
  • Results of the PIONEER AF-PCI Trial
    Read more
  • Registry Focus: Venous Thromboembolism Treatment Registries Tell Us About Everyday Practice?
    Read more
  • What have we learnt in 2015 from GARFIELD-AF and other registries about the management of non-valvular atrial fibrillation in clinical practice?
    Read more
  • Novel oral anticoagulants in different thromboembolic indications
    Read more
  • Dual pathway therapy for acute coronary syndrome: exciting new developments with oral anticoagulation
    Read more
  • First results of the XALIA study: real-world evidence on rivaroxaban for the treatment of deep vein thrombosis
    Read more
  • GARFIELD Atrial Fibrillation Updates
    Read more

Never miss out on the latest news!

Over 4,000 healthcare professionals have already signed up.

Subscribe
When to use a reduced NOAC dose 02:12 min
Join the Conversation

Join the Conversation

Thrombosis Connection, A Healthcare Professionals’ Forum welcomes individuals interested in sharing, developing and fostering innovative solutions in the field of thrombosis.

Join LinkedIn Group